Key result
Physical frailty linked to ~89% higher risk of death, urgent transplant, or LVAD in advanced HF.
Why the study?
To evaluate the prognostic value of physical frailty on mortality in patients with advanced heart failure and compare it directly with the MECKI score.
Does physical frailty assessment provide comparable prognostic value to the MECKI score for predicting adverse outcomes in patients with advanced heart failure?
Cohort (n=104)
Does physical frailty assessment provide comparable prognostic value to the MECKI score for predicting adverse outcomes in patients with advanced heart failure?
Physical frailty assessment offers a simple, low-cost prognostic tool with discriminative performance comparable to the MECKI score in patients with advanced heart failure.
Should not yet change practice in advanced HF; hypothesis-generating for frailty integration with MECKI score.
Background/Objectives: Frailty, a syndrome characterized by diminished physiological reserves and increased vulnerability to stressors, is a strong predictor of adverse outcomes in heart failure. The MECKI (Metabolic Exercise Cardiac Kidney Index) score, derived from cardiopulmonary exercise testing and renal function parameters, has demonstrated prognostic value in HF patients. This study aimed to evaluate the prognostic value of physical frailty on mortality in patients with advanced heart failure and to compare it directly with the MECKI score. Methods: A total of 104 patients with advanced HF receiving optimized guideline-directed medical therapy were prospectively enrolled. At baseline, all patients underwent clinical, echocardiographic, and laboratory assessment and CPET for MECKI score calculation. Physical frailty was assessed using a modified Fried phenotype tailored for HF. The composite endpoint comprised all-cause mortality, urgent heart transplantation, or LVAD implantation. Results: Over a mean follow-up of 30.0 ± 15.3 months, there were 25 deaths, 5 urgent heart transplants, and 1 LVAD implantation. Patients who experienced the composite outcome had significantly worse NYHA class, higher NT-proBNP, lower VO2max, higher VE/VCO2 slope, higher frailty, and higher MECKI score (all p < 0.001). Frailty was significantly correlated with all MECKI score components, as demonstrated by Spearman’s rank correlation analysis. Both frailty (HR = 1.89; 95% CI 1.22–2.93; p = 0.005) and MECKI score (HR = 1.04; 95% CI 1.00–1.08; p = 0.037) independently predicted outcomes. ROC analysis showed high and comparable discriminative performance (AUC = 0.86 for frailty; AUC = 0.88 for MECKI). Conclusions: Physical frailty and MECKI scores independently predict mortality and adverse events in advanced HF. Physical frailty, despite its simplicity and low cost, provides prognostic insight comparable to the MECKI score and may represent a practical alternative when CPET is unavailable.
No takes yet. Share an insight, caveat, or question.
Curcio et al. (2026) conducted a cohort in Advanced heart failure (n=104). Physical frailty vs. MECKI score was evaluated on Composite of all-cause mortality, urgent heart transplantation, or LVAD implantation (HR 1.89, 95% CI 1.22-2.93, p=0.005). Physical frailty independently predicted mortality, urgent transplant, or LVAD in advanced heart failure (HR 1.89; 95% CI 1.22-2.93; p=0.005), with comparable discrimination to the MECKI score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: